Injectable antibiotic formulations and use thereof
Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
1. A non-aqueous composition, comprising:
(i) a mono- or di-hydrate macrolide;
(ii) at least 23% w/w of a first solvent, wherein the first solvent is triacetin;
(iii) a second solvent, wherein the second solvent is a triglyceride solvent; and
(iv) an excipient.
2. The composition of claim 1 , wherein the macrolide is azithromycin.
3. The composition of claim 1 , wherein the first solvent is present in an amount of about 38.0% w/w.
4. The composition of claim 1 , further comprising a surfactant.
5. The composition of claim 4 , wherein the surfactant is castor oil.
6. The composition of claim 5 , wherein the castor oil comprises Polyoxyl 15 Hydroxystearate.
7. The composition of claim 1 , wherein the second solvent is caprylic or caprylic/capric triglycerides.
8. The composition of claim 7 , wherein the second solvent is present in an amount of about 54.0% w/w.
9. The composition of claim 1 , wherein azithromycin is present in an amount of about 2.5-14.0% w/w.
10. The composition of claim 1 , wherein the first solvent is triacetin and the second solvent is caprylic, caprylic or capric triglycerides.
11. The composition of claim 7 , wherein the triglyceride is a C8 triglyceride.
12. The composition of claim 10 , wherein the triglyceride is a C8 triglyceride.
13. The composition of claim 1 , wherein the composition is formulated for injection.
14. A method of treating an infection in a subject weighing less than about 100 pounds, comprising administering an effective amount of a composition of claim 1 .
15. The method of claim 14 , further comprising administering an additional antibiotic in combination with the composition of claim 1 .
16. The method of claim 14 , wherein the subject is a feline.
17. The method of claim 14 , wherein the composition is administered by injection.
18. A composition formulated for injection, comprising about 54.0% w/w caprylic triglycerides; about 38.0% w/w triacetin; Polyoxyl 15 Hydroxystearate; and about 7.0% w/w azithromycin dihydrate.
19. The composition of claim 9 , wherein azithromycin is present in an amount of about 7.0-10.0% w/w.
20. The composition of claim 9 , wherein azithromycin is present in an amount of about 3.5 or 7.0% w/w.
21. The method of claim 17 , wherein the administration is subcutaneous injection.
22. The method of claim 17 , wherein the administration is intramuscular injection.
23. The method of claim 14 , wherein administering comprises injecting a single dose of the composition.
24. The method of claim 23 , further comprising administering a second dose of the composition.
25. A non-aqueous composition, comprising:
(i) a macrolide;
(ii) at least 23% w/w of a first solvent, wherein the first solvent is triacetin;
(iii) a second solvent, wherein the second solvent is a triglyceride solvent; and
(iv) an excipient.